Skip to main content

Table 4 ECHO findings in female HF types

From: Clinical characteristics and in-hospital outcome of heart failure in women: a single center registry from Egyptian cardiac care unit

  

Mean

P value

LVEDd (mm)

HF-REF

39.07 ± 25

0.004

HF-PEF

17.53 ± 22

 

LVESd (mm)

HFrEF

23.84 ± 21

0.025

HFpEF

15.05 ± 20

 

IVS (mm)

HFrEF

5.42 ± 5

0.021

HFpEF

3.40 ± 4

 

PWT (mm)

HFrEF

5.36 ± 5

0.018

HFpEF

3.30 ± 4

 

EF%

HFrEF

33.88 ± 12

0.001

HFpEF

61.96 ± 12

 

LA (mm)

HFrEF

21.50 ± 19

0.012

HFpEF

12.87 ± 16

 

AO (mm)

HFrEF

28.26 ± 16.5

0.015

HFpEF

10.76 ± 15

 

TAPSE (mm)

HFrEF

6.84 ± 5.1

0.235

HFpEF

8.65 ± 4

 

EPASP (mm)

HFrEF

42.26 ± 13

0.503

HFpEF

40.12 ± 20

 

E/A wave

HFrEF

1.47 ± 1

0.409

HFpEF

1.67 ± 1

 

E/e' wave

HFrEF

18.31 ± 9.5

0.023

HFpEF

23.62 ± 12

 

RWMA

HFrEF

62 (85%)

0.002

HFpEF

27 (60%)

 
  1. HFrEF heart failure with reduced ejection fraction, HFpEF heart failure with preserved ejection fraction, LVEDd left ventricular end diastolic diameter, LVESd left ventricular end systolic diameter, IVS interventricular thickness, PWT posterior wall thickness, EF% ejection fraction, LA left atrium, Ao aortic root diameter, TAPSE tricuspid annular plane systolic excursion, EPASP estimated pulmonary artery systolic pressure, E?A mitral flow early diastolic velocity, A mitral inflow atrial diastolic velocity, E/e mitral flow early diastolic velocityto early diastolic mitral annular velocity, RWMA regional wall motion abnormalities